Brave New World

The fiction defines the nightmare. The table scores what reality has already built — each symptom checkable, each status sourced, the absences counted as honestly as the arrivals.

The symptoms

	symptom	the evidence	as of
✅	Population-scale algorithmic dopamine loopspresent	DataReportal's Digital 2025 report counts 5.66 billion social-media users, about 68% of humanity, averaging roughly 2h21m daily on social platforms (Feb 2025). The WHO's ICD-11 has listed gaming disorder as a diagnosable addictive behaviour since 2018, and researchers now apply the same criteria to problematic social-media use; intermittent-reward design (infinite scroll, pull-to-refresh) is documented. [source]	2025-02
✅	Mood-management pharmacology at mass prevalencepresent	CDC National Health Interview Survey data show US adult antidepressant use rose from 9.8% in 2019 to 11.4% in 2023, reaching 15.3% of women in 2023. OECD figures put Iceland near 157 defined daily doses per 1,000 inhabitants in 2022, among the world's highest. This is medical treatment, not engineered pacification. [source]	2025-06
✅	Engineered distraction economy (attention sold as a metered commodity)present	The attention economy is a named, revenue-measured industry; the global native-advertising market was projected near $400 billion by 2025. Platforms deploy persuasive-design patterns explicitly modelled on slot-machine reinforcement, and engagement telemetry is collected and traded at fine time-series granularity. [source]	2025-06
◐	Reproductive decoupling via artificial wombs (full ectogenesis)partial	Partial decoupling is routine: IVF, gamete freezing, and surrogacy. Full ectogenesis does not exist; as of mid-2026 no human has been gestated outside a body. CHOP's EXTEND device holds FDA breakthrough designation, but its planned first-in-human trials target premature infants at 22-24 weeks, not conception-to-birth, and had not begun as of June 2026. [source]	2026-06
◐	Caste assigned by optimization (algorithmic sorting plus embryo selection)partial	Algorithmic sorting in credit, hiring, insurance, and policing is documented to entrench inequality. Commercial polygenic embryo screening for IQ and non-disease traits launched in 2025 (Herasight, Nucleus); Orchid screens health risks only. Selection is voluntary, costly, rare, and banned in the UK, Germany, and France, not a state-assigned station or conditioned caste. [source]	2026-05
—	A soma equivalent: a side-effect-free, state-issued mass pacifierabsent	No engineered, hangover-free drug is distributed or mandated by any state for social pacification. Cannabis is legal for adult use in 24 US states with past-month use of 15-25% (2023 data, reported 2026), but it carries health costs and no docility mandate; antidepressants treat illness and have side effects. Soma as social policy, costless contentment by design, does not exist. [source]	2026-05

The honest read

Huxley's machine runs on pleasure, and the pleasure infrastructure is largely built: population-scale dopamine loops, a metered attention market, and antidepressants at record prevalence are all measurably present. What is absent is the coercive core. There is no soma (no engineered, costless, state-issued contentment), no hatchery (full ectogenesis does not exist), and no assigned caste (embryo optimization is voluntary, rare, and widely banned rather than a birth sentence). The real barrier is not technical capacity but the absence of a state that manufactures and mandates these tools for docility; today's versions are commercial and opt-in, a different failure mode. Base rate: most of these trends predate the internet and none evidences a coordinated design, so read the board as convergence, not conspiracy.